Eidogen-Sertanty Licenses Target Informatics Platform to NCBI
Complete the form below to unlock access to ALL audio articles.
Eidogen-Sertanty, Inc. has announced that they have licensed their Target Informatics Platform™ (TIP™) to the U.S. National Library of Medicine’s National Center for Biotechnology Information (NCBI), based in Bethesda, MD.
Under the terms of the annual license, scientists at the NCBI will have access to the TIP structural knowledgebase as well as Eidogen-Sertanty’s EVE Comparative Visualizer.
"We’re extremely pleased to be collaborating with the NCBI. They have developed a number of outstanding and widely used informatics platforms over the years, and I’m optimistic that our interaction will lead to new high impact advances," said Derek Debe, Eidogen-Sertanty’s Chief Scientific Officer.
